{"id":16934,"date":"2024-03-21T14:37:37","date_gmt":"2024-03-21T05:37:37","guid":{"rendered":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/?page_id=16934"},"modified":"2026-01-08T16:35:43","modified_gmt":"2026-01-08T07:35:43","slug":"results","status":"publish","type":"page","link":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/department\/shinryoka\/syunai\/results\/","title":{"rendered":"\u816b\u760d\u5185\u79d1 \u81e8\u5e8a\u7814\u7a76\u767a\u8868\u5b9f\u7e3e"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">\u5e73\u621028\u5e74\u5ea6\uff5e\u4ee4\u548c6\u5e74\u5ea6<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">\u4ee4\u548c6\u5e74\u5ea6<\/h3>\n\n\n\n<p>\u3010\u539f\u8457\u3011<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Shiraishi K, Okada M, Yamamoto S, Matsubara Y, Masuishi T, Shimozaki K, Yamamoto Y, Hirose S, Sugiyama K, Furuta M, Machida N, Takahashi N, Yoshii T, Kito Y, Tsuzuki T, Boku S, Tsuchihashi K, Sugaya A, Takayama T, Komori A, Mitani S, Matsumoto T, Nishimura T, Hirata K.The efficacy and safety of FOLFOX therapy for advanced esophageal squamous cell carcinoma. Sci Rep 2025; 15:8031.<\/li>\n<\/ol>\n\n\n\n<p>\u3010\u5b66\u4f1a\u767a\u8868\u3011<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>\u77e2\u82b1 \u4fe1\u4e9c\uff0c\u83c5\u8c37 \u660e\u5fb3\uff0c\u85e4\u5c3e \u9ad8\u884c\uff0c\u4e09\u6a4b \u5f70\u4e00\uff0c\u77f3\u9ed2 \u613c\u543e\uff0c\u6589\u85e4 \u4ec1\u662d\uff0c\u5c0f\u5cf6 \u5bdb \u539f\u767a\u4e0d\u660e\u304c\u3093\u3068\u3057\u3066\u7d39\u4ecb\u3055\u308c\u7279\u767a\u6027\u591a\u4e2d\u5fc3\u6027Castleman\u75c5(iMCD)\u3068\u8a3a\u65ad\u3057\u305f\u591a\u767a\u30ea\u30f3\u30d1\u7bc0\u816b\u8139\u306e\u4e00\u4f8b \u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u7dcf\u4f1a\u3000\u3053\u3068\u306f\u3058\u3081\u30002024.4\uff08\u6771\u4eac\uff09<\/li>\n\n\n\n<li>\u83c5\u8c37\u660e\u5fb3\u3001\u65e5\u5409\u96c5\u4e5f\u3000A case of anorectal malignant melanoma treated with immune checkpoint inhibitor after anorectal sparing surgery and irradiation \u7b2c110\u56de\u65e5\u672c\u6d88\u5316\u5668\u75c5\u5b66\u4f1a\u7dcf\u4f1a\u30002024.5\uff08\u5fb3\u5cf6)<\/li>\n\n\n\n<li>\u702c\u5c71\u4f91\u4eae\u3001\u6749\u5c71\u6cbb\u4e45\u3001\u5c71\u53e3\u53f3\u771f\u3001\u672c\u591a\u5bdb\u4e4b\u3001\u77f3\u6a4b\u8087\u3001\u5c71\u5ca1\u6b63\u6cbb\u3001\u83c5\u8c37\u660e\u5fb3\u3001\u5927\u95a2\u745e\u6cbb\u3001\u8352\u6728\u771e\u88d5\u3001\u4e94\u982d\u4e09\u79c0\u3001\u5929\u8c9d\u8ce2\u4e8c\u3000\u6d88\u5316\u7ba1\u7570\u7269\u306b\u304a\u3051\u308b\u5185\u8996\u93e1\u7684\u7570\u7269\u9664\u53bb\u8853\u306e\u6709\u52b9\u6027\u306e\u691c\u8a0e JDDW2024\u30002024.10\uff08\u795e\u6238\uff09<\/li>\n\n\n\n<li>\u5c71\u5ca1\u6b63\u6cbb, \u4e94\u982d\u4e09\u79c0, \u702c\u5c71\u4f91\u4eae, \u6749\u5c71\u6cbb\u4e45, \u5c71\u53e3\u53f3\u771f, \u672c\u591a\u5bdb\u4e4b, \u77f3\u6a4b\u8087, \u83c5\u8c37\u660e\u5fb3, \u5927\u95a2\u745e\u6cbb, \u8352\u6728\u771e\u88d5, \u5929\u8c9d\u8ce2\u4e8c\u300010mm\u4ee5\u4e0b\u306e\u65e9\u671f\u5927\u8178\u764c\u3068\u9ad8\u7570\u578b\u5ea6\u817a\u816b\u306e\u5185\u8996\u93e1\u7684\u6cbb\u7642\u72b6\u6cc1 JDDW2024\u30002024.10\uff08\u795e\u6238\uff09<\/li>\n\n\n\n<li>\u5800\u5149\u96c4, \u85e4\u5c3e\u9ad8\u884c, \u9ed2\u5ddd\u5b89\u6e80, \u9577\u8c37\u5ddd\u96c4\u4e00, \u5c0f\u5cf6\u5bdb, \u83c5\u8c37\u660e\u5fb3, \u4e09\u6a4b\u5f70\u4e00, \u77f3\u9ed2\u613c\u543e. \u5358\u4e00\u65bd\u8a2d\u306b\u304a\u3051\u308b\u30a8\u30ed\u30c4\u30ba\u30de\u30d6\u306e\u9577\u671f\u6cbb\u7642\u304c\u53ef\u80fd\u3060\u3063\u305f\u75c7\u4f8b\u306b\u3064\u3044\u3066\u306e\u691c\u8a0e. \u7b2c86\u56de\u65e5\u672c\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, 2024.10\uff08\u4eac\u90fd\uff09<\/li>\n\n\n\n<li>\u9ad8\u7530\u6e05\u5b50 \u83c5\u8c37\u660e\u5fb3 \u4e09\u6a4b\u5f70\u4e00 \u5ddd\u5d0e\u666e\u53f8 \u85e4\u5c3e\u9ad8\u884c \u5c0f\u5cf6\u5bdb \u5927\u795e\u6b63\u5b8f\u3000\u7acb\u539f\u8302\u6a39 \u7530\u4e2d\u548c\u7f8e \u4e0a\u7530\u771f\u7531\u7f8e \u5316\u5b66\u7642\u6cd5\u30b3\u30f3\u30b5\u30eb\u30c6\u30fc\u30b7\u30e7\u30f3\u30c1\u30fc\u30e0\u306e\u6d3b\u52d5\u5831\u544a \u7b2c62\u56de\u5168\u56fd\u81ea\u6cbb\u4f53\u75c5\u9662\u5b66\u4f1a\u30002024.11\uff08\u65b0\u6f5f\uff09<\/li>\n\n\n\n<li>\u67cf\u5f69\u7e54\u3001\u83c5\u8c37\u660e\u5fb3\u3001\u5ee3\u5d8b\u60a0\u4e00\u3001\u5927\u795e\u6b63\u5b8f\u3001\u52a9\u5ddd\u5343\u7d75\u3001\u7cf8\u8cc0\u667a\u5b50\u3001\u91ce\u5d0e\u8ca2\u3000\u81b5\u81d3\u304c\u3093\u30fb\u80c6\u9053\u304c\u3093\u6559\u5ba4\u306e\u53d6\u308a\u7d44\u307f\u306e\u52b9\u679c\u3000\u7b2c62\u56de\u5168\u56fd\u81ea\u6cbb\u4f53\u75c5\u9662\u5b66\u4f1a\u30002024.11\uff08\u65b0\u6f5f\uff09<\/li>\n\n\n\n<li>Sunakawa Y, Inoue E, Kotani D, Denda T, Inagaki C, Kashiwada T, Horita Y, Sugaya A, Suwa Y, Ohta T, Kuramochi H, Oshima K, Shiozawa M, Yuki S, Tsuji A, Muro K, Ichikawa W, Fujii M. Encorafenib and cetuximab with\/without binimetinib therapies for BRAF-mutated metastatic colorectal cancer patients with prognostic factors: the BEETS trial (JACCRO CC-18). ASCO-GI, 2025.1\uff08USA, \u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\uff09<\/li>\n\n\n\n<li>\u83c5\u8c37\u660e\u5fb3, \u5929\u8c9d\u8ce2\u4e8c, \u77f3\u9ed2\u613c\u543e, \u8352\u6728\u771e\u88d5, \u77f3\u6a4b\u8087, \u672c\u591a\u5bdb\u4e4b, \u5927\u95a2\u745e\u6cbb, \u4e94\u982d\u4e09\u79c0, \u702c\u5c71\u4f91\u4eae, \u6749\u5c71\u6cbb\u4e45, \u5c0f\u5cf6\u5bdb. \u30be\u30eb\u30d9\u30c4\u30ad\u30b7\u30de\u30d6\u6295\u4e0e\u306b\u304a\u3051\u308b\u30c1\u30fc\u30e0\u533b\u7642\u306e\u5b9f\u8df5 \u7b2c97\u56de\u65e5\u672c\u80c3\u764c\u5b66\u4f1a\u7dcf\u4f1a, 2025.3\uff08\u540d\u53e4\u5c4b\uff09<\/li>\n\n\n\n<li>\u83c5\u8c37\u660e\u5fb3, \u9ad8\u7530\u6e05\u5b50, \u4e09\u6a4b\u5f70\u4e00, \u5ddd\u5d0e\u666e\u53f8, \u85e4\u5c3e\u9ad8\u884c, \u5927\u795e\u6b63\u5b8f, \u7acb\u539f\u8302\u6a39, \u7530\u4e2d\u548c\u7f8e, \u4e0a\u7530\u771f\u7531\u7f8e, \u5c0f\u5cf6\u5bdb. \u5316\u5b66\u7642\u6cd5\u30b3\u30f3\u30b5\u30eb\u30c6\u30fc\u30b7\u30e7\u30f3\u30c1\u30fc\u30e0\u3068\u816b\u760d\u5185\u79d1\u306e\u5f79\u5272 \u7b2c22\u56de\u65e5\u672c\u81e8\u5e8a\u816b\u760d\u5b66\u4f1a\u7dcf\u4f1a, 2025.3\uff08\u795e\u6238\uff09<\/li>\n\n\n\n<li>\u67f3\u5ddd\u5fb9\u3001\u897f\u6751\u6587\u543e\u3001\u5965\u6751\u654f\u4e4b\u3001\u7530\u6751\u745b\u91cc\u3001\u539f\u91ce\u6676\u4ec1\u3001\u677e\u6c38\u62d3\u4e5f\u3001\u5ee3\u5d8b\u60a0\u4e00\u3001\u7ae0\u7af6\u7acb\u3001\u83c5\u8c37\u660e\u5fb3\u3001\u77f3\u9ed2\u613c\u543e\u3001\u5929\u8c9d\u8ce2\u4e8c\u3001\u5ddd\u5d0e\u666e\u53f8\u3001\u9577\u4e95\u5b8f\u6a39\u3001\u548c\u7530\u9686\u5fd7\u3001\u6301\u7530\u96c4\u5b50\u3001\u6b66\u5185\u4fdd\u654f\u3001\u5c71\u7e23\u61b2\u53f8\u3001\u83c5\u91ce\u76f4\u7f8e\u3001\u5185\u7530\u6587\u5f66\u3001\u798f\u6fa4\u667a\u3001\u6b66\u5ddd\u5bdb\u6a39 \u8328\u57ce\u770c\u7acb\u4e2d\u592e\u75c5\u9662\u306b\u304a\u3051\u308b\u982d\u9838\u90e8\u60aa\u6027\u816b\u760d\u6cbb\u7642\u306e\u5404\u79d1\u306e\u9023\u643a\u306b\u3064\u3044\u3066 \u7b2c33\u56de\u8328\u57ce\u770c\u6b6f\u79d1\u533b\u5b66\u4f1a\u30002025.3 \uff08\u6c34\u6238\uff09<\/li>\n<\/ol>\n\n\n\n<p>\u3010\u8b1b\u6f14\u3011<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>\u83c5\u8c37\u660e\u5fb3\u3000Erbitux Academic cutting-edge lecture\u300c\u6297EGFR\u6297\u4f53\u306e\u526f\u4f5c\u7528\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u306b\u3064\u3044\u3066\u300d\u30002024.4 \uff08Web\uff09<\/li>\n\n\n\n<li>\u77f3\u9ed2\u613c\u543e\u300c\u660e\u65e5\u304b\u3089\u3067\u304d\u308b\u300c\u304c\u3093\u30b2\u30ce\u30e0\u533b\u7642\u300d\u304c\u3093\u30b2\u30ce\u30e0\u533b\u7642\u6982\u8ad6\u300d\u3000\u304c\u3093\u30b2\u30ce\u30e0\u51fa\u524d\u8b1b\u5ea7\u30002024.5\uff08\u6c34\u6238\u6e08\u751f\u4f1a\u75c5\u9662\uff09\u3000<\/li>\n\n\n\n<li>\u83c5\u8c37\u660e\u5fb3\u3000GI cancer Chemotherapy Meeting 2024 in Mito \u300c\u304c\u3093\u30b2\u30ce\u30e0\u691c\u67fb\u4f53\u5236\u306b\u3064\u3044\u3066\u300d2024.5 \uff08Web\uff09<\/li>\n\n\n\n<li>\u83c5\u8c37\u660e\u5fb3\u3000\u98df\u9053\u764c\u30aa\u30d7\u30b8\u30fc\u30dcWeb lecture 2024.6\uff08Web\uff09<\/li>\n\n\n\n<li>\u83c5\u8c37\u660e\u5fb3\u3000ILD Management Web Seminar \uff5e\u85ac\u5264\u6027\u80ba\u969c\u5bb3\u306b\u3064\u3044\u3066\u8003\u3048\u308b\uff5e\u30002024.7\uff08Web\uff09<\/li>\n\n\n\n<li>\u77f3\u9ed2\u613c\u543e\u300c\u9662\u5185\u5916\u306e\u30c1\u30fc\u30e0\u3067\u652f\u3048\u308b\u514d\u75ab\u30c1\u30a7\u30c3\u30af\u30dd\u30a4\u30f3\u30c8\u963b\u5bb3\u5264\u306e\u526f\u4f5c\u7528\u5bfe\u7b56\u300dimAE Team Management Seminar 2024.9 (Web)<\/li>\n\n\n\n<li>\u83c5\u8c37\u660e\u5fb3\u3000\u98df\u9053\u764cHybrid Web Seminar \uff5e\u9032\u884c\u518d\u767a\u98df\u9053\u304c\u3093\u306e\u85ac\u7269\u7642\u6cd5\u306b\u304a\u3051\u308bClinical Question\uff5e\u30002024.9 \uff08Web\uff09<\/li>\n\n\n\n<li>\u77f3\u9ed2\u613c\u543e\u300c\u306a\u305c\u3001\u304c\u3093\u306f\u65e9\u671f\u767a\u898b\u30fb\u65e9\u671f\u6cbb\u7642\u304c\u671b\u307e\u3057\u3044\u306e\u304b\uff1f\u304c\u3093\u306b\u306a\u3063\u3066\u304b\u3089\u306e\u3053\u3068\u3092\u3088\u304f\u77e5\u308c\u3070\u308f\u304b\u308a\u307e\u3059\u3002\u300d\u3000R6\u5e74\u5ea6\u304c\u3093\u4e88\u9632\u63a8\u9032\u54e1\u990a\u6210\u8b1b\u7fd2\u4f1a\u30002024.11\uff08\u3064\u304f\u3070\u5e02\uff09<\/li>\n\n\n\n<li>\u77f3\u9ed2\u613c\u543e\u300c\u306a\u305c\u3001\u304c\u3093\u306f\u65e9\u671f\u767a\u898b\u30fb\u65e9\u671f\u6cbb\u7642\u304c\u671b\u307e\u3057\u3044\u306e\u304b\uff1f\u304c\u3093\u306b\u306a\u3063\u3066\u304b\u3089\u306e\u3053\u3068\u3092\u3088\u304f\u77e5\u308c\u3070\u308f\u304b\u308a\u307e\u3059\u3002\u300d\u3000R6\u5e74\u5ea6\u304c\u3093\u4e88\u9632\u63a8\u9032\u54e1\u990a\u6210\u8b1b\u7fd2\u4f1a\u30002024.12\uff08\u6c34\u6238\u5e02\uff09<\/li>\n\n\n\n<li>\u77f3\u9ed2\u613c\u543e\u300cICI\u306e\u526f\u4f5c\u7528\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\u3001\u30ec\u30b8\u30e1\u30f3\u7ba1\u7406\u2010\u85ac\u5264\u5e2b\u3001\u533b\u5e2b\u306e\u305d\u308c\u305e\u308c\u306e\u7acb\u5834\u304b\u3089\u2010\u300d Immuno Oncology Pharmacy Seminar 2024.12\uff08Web\uff09<\/li>\n\n\n\n<li>\u77f3\u9ed2\u613c\u543e\u300c\u3044\u307e\u3055\u3089\u805e\u3051\u306a\u3044\u304c\u3093\u30b2\u30ce\u30e0\u533b\u7642\uff08\u57fa\u790e\u7de8\uff09\u3053\u306e\u7814\u4fee\uff11\u56de\u3067\u3001\u3068\u308a\u3042\u3048\u305a\u6642\u4ee3\u306b\u8ffd\u3044\u3064\u3053\u3046\u300d \u304c\u3093\u533b\u7642\u5f93\u4e8b\u8005\u7814\u4fee\u4f1a2025. 1 (\u8328\u57ce\u770c\u7acb\u4e2d\u592e\u75c5\u9662 Web)<\/li>\n\n\n\n<li>\u77f3\u9ed2\u613c\u543e\u300c\u660e\u65e5\u304b\u3089\u3067\u304d\u308b\u300c\u304c\u3093\u30b2\u30ce\u30e0\u533b\u7642\u300d\u3000\u304c\u3093\u30b2\u30ce\u30e0\u533b\u7642\u6982\u8ad6\u300d \u304c\u3093\u30b2\u30ce\u30e0\u51fa\u524d\u8b1b\u5ea7 2025. 1\uff08\u5c0f\u5c71\u8a18\u5ff5\u75c5\u9662\uff09<\/li>\n\n\n\n<li>\u77f3\u9ed2\u613c\u543e\u300c\u304c\u3093\u30b2\u30ce\u30e0\u533b\u7642\u300d \u770c\u653f\u51fa\u524d\u8b1b\u5ea7\u30002025.3\u3000(\u6c34\u6238\u5e02\u6c11\u4f1a\u9928)<\/li>\n<\/ol>\n\n\n\n<h3 class=\"wp-block-heading\">\u4ee4\u548c5\u5e74\u5ea6<\/h3>\n\n\n\n<p>\u3010\u8ad6\u6587\u3011<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>\u798f\u7530\u958b\u4eba\u3001\u82e5\u6749\u6b63\u6a39\u3001\u5de5\u85e4\u5b8f\u6a39\u3001\u5965\u91ce\u8cb4\u4e4b\u3001\u661f\u5ddd\u771f\u6709\u7f8e\u3001\u65e5\u5409\u96c5\u4e5f\u3001\u5ddd\u5d0e\u666e\u53f8\u3001\u5409\u898b\u5bcc\u6d0b\u3001\u77f3\u9ed2\u613c\u543e\u3001\u98ef\u5d8b\u9054\u751f\u3001\u91ce\u5cf6\u5b5d\u4e4b\u3001\u4eac\u7530\u6709\u4ecb2\u56de\u306e\u5207\u9664\u3068\u5316\u5b66\u7642\u6cd5\u306b\u3088\u308a\u9577\u671f\u751f\u5b58\u304c\u5f97\u3089\u308c\u3066\u3044\u308b\u5f8c\u8179\u819c\u6ed1\u819c\u8089\u816b\u306e1\u4f8b. \u6d88\u5316\u5668\u5916\u79d1\u300146\uff0810\uff091137-1140\u30012023<\/li>\n<\/ol>\n\n\n\n<h3 class=\"wp-block-heading\">\u4ee4\u548c4\u5e74\u5ea6<\/h3>\n\n\n\n<p>\u3010\u539f\u8457\u3011<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Sekiya T, Ogura Y, Kai H, Kawaguchi A, Okawa S, Hirohama M, Kuroki T, Morii W, Hara A, Hiramatsu Y, Hitomi S, Kawakami Y, Arakawa Y, Maruo K, Chiba S, Suzuki H, Kojima H, Tachikawa H, Yamagata K. TMPRSS2 gene polymorphism common in east Asians confers decreased COVID-19 susceptibility. Front Microbiol 2022; 13:943877.<\/li>\n<\/ol>\n\n\n\n<p>\u3010\u5b66\u4f1a\u767a\u8868\u3011<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>\u5c0f\u5cf6\u5bdb. Comprehensive Oral Care\u306b\u3088\u308b\u60a3\u8005Well-being\u3078\u306e\u8ca2\u732e\u3000\uff5e\u533b\u79d1\u6b6f\u79d1\u9023\u643a\u306e\u5728\u308a\u65b9\u3092\u8003\u3048\u308b\uff5e\u3000\u7b2c\uff13\uff17\u56de\u65e5\u672c\u75c5\u9662\u6b6f\u79d1\u53e3\u8154\u5916\u79d1\u5354\u8b70\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a\uff08\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff09, 2022.11\uff08\u5e55\u5f35\uff09<\/li>\n\n\n\n<li>Fujio T, Saito H, Iijima T, Abe K, Koido A, Kurokawa Y, Hasegawa Y, Kojima H, Hori M. Clinical significance of SLAMF7 expression in AITL. \u7b2c84\u56de\u65e5\u672c\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, 2022.10\uff08\u798f\u5ca1\uff09<\/li>\n\n\n\n<li>\u5824\u80b2\u4ee3, \u5c71\u672c\u6b63\u82f1, \u85e4\u5c3e\u9ad8\u884c, \u54c1\u5ddd\u7be4\u53f8, \u5c0f\u6749\u4fe1\u6625, \u9ad8\u91ce\u5f25\u5948, \u5c71\u672c\u6643, \u718a\u8c37\u9686\u5fd7, \u4e09\u6728\u5fb9, \u5de5\u85e4\u5927\u8f14, \u8c4a\u7530\u8302\u96c4, \u4e2d\u6751\u88d5\u4e00, \u5ddd\u4e95\u4fe1\u5b5d, \u5927\u6a4b\u4e00\u8f1d, \u7c73\u91ce\u7422\u54c9, \u5c0f\u5cf6\u5bdb. \u9aa8\u9ac4\u816b\u306b\u5bfe\u3059\u308bVRD\u7642\u6cd5\u3068\u4f4e\u7528\u91cf\u30b7\u30af\u30ed\u30d5\u30a9\u30b9\u30d5\u30a1\u30df\u30c9+\u30dc\u30eb\u30c6\u30be\u30df\u30d6\u306b\u3088\u308b\u5e79\u7d30\u80de\u52d5\u54e1\u30fb\u81ea\u5bb6\u79fb\u690d\u306e\u6709\u52b9\u6027. \u7b2c\uff14\uff14\u56de\u65e5\u672c\u9020\u8840\u30fb\u514d\u75ab\u7d30\u80de\u7642\u6cd5\u5b66\u4f1a\u7dcf\u4f1a, 2022.5\uff08\u6a2a\u6d5c\uff09<\/li>\n\n\n\n<li>\u83c5\u8c37\u660e\u5fb3\u3001\u77f3\u9ed2\u613c\u543e\u3001\u5c0f\u5cf6\u5bdb. \u5f53\u9662\u306b\u304a\u3051\u308b\u553e\u6db2\u817a\u764c\u75c7\u4f8b\u306b\u304a\u3051\u308b\u30e9\u30ed\u30c8\u30ec\u30af\u30c1\u30cb\u30d6\u306e\u4f7f\u7528\u7d4c\u9a13\u3000\u7b2c20\u56de\u65e5\u672c\u81e8\u5e8a\u816b\u760d\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u3001 2023.3\uff08\u798f\u5ca1\uff09<\/li>\n\n\n\n<li>\u77f3\u9ed2\u613c\u543e\u3001\u5c0f\u5cf6\u5bdb\u3001\u4e09\u6a4b\u5f70\u4e00\u3001\u83c5\u8c37\u660e\u5fb3\u3001\u9f4b\u85e4\u8aa0\u3001\u77f3\u5802\u4f73\u4e16\u3001\u5927\u795e\u6b63\u5b8f\u3001\u963f\u90e8\u9999\u7e54\u3001\u5c0f\u4e95\u6238\u7dbe\u5b50. \u30c1\u30fc\u30e0\u30ef\u30fc\u30af\u3067\u652f\u3048\u308b\u304c\u3093\u907a\u4f1d\u5b50\u30d1\u30cd\u30eb\u691c\u67fb. \u7b2c60\u56de\u5168\u56fd\u81ea\u6cbb\u4f53\u75c5\u9662\u5b66\u4f1a\u30012022.11\uff08\u6c96\u7e04\uff09<\/li>\n\n\n\n<li>\u77f3\u5802\u4f73\u4e16, \u5927\u795e\u6b63\u5b8f, \u83c5\u8c37\u660e\u5fb3\u3001 \u9f4b\u85e4\u8aa0\u3001 \u963f\u90e8\u9999\u7e54\u3001\u77f3\u9ed2\u613c\u543e. \u304c\u3093\u30b2\u30ce\u30e0\u30d7\u30ed\u30d5\u30a1\u30a4\u30ea\u30f3\u30b0\u691c\u67fb\u306b\u304a\u3051\u308b\u751f\u6b96\u7d30\u80de\u7cfb\u5217\u306e\u75c5\u7684variant\u306b\u5bfe\u3059\u308b\u591a\u8077\u7a2e\u30bf\u30b9\u30af\u30fb\u30b7\u30a7\u30a2\u30ea\u30f3\u30b0\u306b\u3064\u3044\u3066\u306e\u691c\u8a0e\u3001\u7b2c28\u56de\u65e5\u672c\u907a\u4f1d\u6027\u816b\u760d\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30002022.6\uff08web\uff09<\/li>\n\n\n\n<li>\u767d\u77f3\u548c\u5bdb\u3001\u6749\u5c71\u572d\u53f8\u3001\u6fa4\u4e95\u5eb7\u5f25\u3001\u4e0b\u5d5c\u5553\u592a\u90ce\u3001\u5ca1\u7530\u771f\u592e\u3001\u677e\u539f \u7950\u6a39\u3001\u53e4\u7530\u5149\u5bdb\u3001\u5ee3\u702c\u512a\u3001\u5c0f\u68ee\u6893\u3001\u4e09\u8c37\u8aa0\u4e00\u90ce\u3001\u6734\u5c06\u6e90\u3001\u897f\u6751\u5c1a\u3001\u571f\u6a4b\u8ce2\u53f8\u3001\u6728\u85e4\u967d\u4ecb\u3001\u83c5\u8c37\u660e\u5fb3\u3001\u821b\u77f3\u4fca\u6a39\u3001\u677e\u672c\u4fca\u5f66\u3001\u7b51\u6728\u9686\u96c4\u3001\u5409\u4e95\u8cb4\u5b50\u3001\u5e73\u7530\u8ce2\u90ce. \u9032\u884c\u518d\u767a\u98df\u9053\u6241\u5e73\u4e0a\u76ae\u764c\u306e\u4e00\u6b21\u6cbb\u7642\u306b\u304a\u3051\u308bFOLFOX\u7642\u6cd5\u306b\u95a2\u3059\u308b\u591a\u65bd\u8a2d\u5f8c\u65b9\u8996\u7684\u7814\u7a76\u3001\u7b2c20\u56de\u65e5\u672c\u81e8\u5e8a\u816b\u760d\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30012023.3\uff08\u798f\u5ca1\uff09<\/li>\n\n\n\n<li>\u9234\u6728\u5609\u6cbb\u3001\u7530\u6751\u667a\u5b8f\u3001\u8352\u6728\u771e\u88d5\u3001\u83c5\u8c37\u660e\u5fb3\u3001\u93d1\u6728\u5b5d\u4e4b\u3001\u5c0f\u5cf6\u5bdb\u3001\u5e02\u585a\u4e9c\u7531\u7f8e\u3001\u5cf6\u7530\u6d69\u548c\u3001\u5c71\u4e0b\u3086\u3046\u304b\u3001\u9234\u6728\u7f8e\u52a0. \u30df\u30b3\u30d5\u30a7\u30ce\u30fc\u30eb\u9178\u306e\u8840\u6db2\u4e2d\u6fc3\u5ea6\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\u306b\u3088\u308a\u30b9\u30c6\u30ed\u30a4\u30c9\u62b5\u6297\u6027\u514d\u75ab\u95a2\u9023\u809d\u969c\u5bb3\u306e\u30b3\u30f3\u30c8\u30ed\u30fc\u30eb\u3092\u8a66\u307f\u305f\u80ba\u817a\u764c\u306e\u4e00\u75c7\u4f8b\u3001\u7b2c20\u56de\u65e5\u672c\u81e8\u5e8a\u816b\u760d\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a 2023.3\uff08\u798f\u5ca1\uff09<\/li>\n<\/ol>\n\n\n\n<p>\u3010\u8b1b\u6f14\u3011<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>\u83c5\u8c37\u660e\u5fb3\u300c\u304c\u3093\u30b2\u30ce\u30e0\u533b\u7642\u9023\u643a\u75c5\u9662\u3067\u306e\u53d6\u308a\u7d44\u307f NTRK\u878d\u5408\u907a\u4f1d\u5b50\u691c\u51fa\u3068\u30f4\u30a1\u30a4\u30c8\u30e9\u30c3\u30af\u30d3\u00ae\u6295\u4e0e\u7d4c\u9a13\u306e\u5171\u6709\u300d\u6176\u5fdc\u5927\u5b66\u304c\u3093\u30b2\u30ce\u30e0\u533b\u7642\u9023\u643a\u75c5\u9662\u8b1b\u6f14\u4f1a\u3000\uff08Web\uff092022.4<\/li>\n\n\n\n<li>\u77f3\u9ed2\u613c\u543e\u300c\u591a\u8077\u7a2e\u3067\u652f\u3048\u308b\u304c\u3093\u6cbb\u7642 \u3084\u308a\u6b8b\u3057\u305f\u3053\u3068\u306e\u306a\u3044\u3088\u3046\u306b\u3001 \u4eca\u3001\u3067\u304d\u308b\u3053\u3068\u300d\u7de9\u548c\u30b1\u30a2\u9023\u643a\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9\u30002022.6<\/li>\n\n\n\n<li>\u83c5\u8c37\u660e\u5fb3\u300c\u5f53\u9662\u306b\u304a\u3051\u308b\u80c3\u764c\u5f8c\u65b9\u6cbb\u7642\u3067\u306e\u30ed\u30f3\u30b5\u30fc\u30d5\u306e\u4f7f\u7528\u306e\u5b9f\u969b\u300d\u3000GI Cancer Chemotherapy Meeting 2022 in Mito\u30002022.6\uff08Web\uff09<\/li>\n\n\n\n<li>\u83c5\u8c37\u660e\u5fb3\u300c\u304c\u3093\u30b2\u30ce\u30e0\u533b\u7642\u9023\u643a\u75c5\u9662\u3067\u306e\u53d6\u308a\u7d44\u307f\u3000NTRK\u878d\u5408\u907a\u4f1d\u5b50\u691c\u51fa\u3068\u30f4\u30a1\u30a4\u30c8\u30e9\u30c3\u30af\u30d3\u6295\u4e0e\u7d4c\u9a13\u306e\u5171\u6709\u300d\u56fd\u7acb\u304c\u3093\u7814\u7a76\u30bb\u30f3\u30bf\u30fc\u4e2d\u592e\u75c5\u9662\u304c\u3093\u30b2\u30ce\u30e0\u533b\u7642\u9023\u643a\u75c5\u9662\u8b1b\u6f14\u4f1a\u30002022.7<\/li>\n\n\n\n<li>\u83c5\u8c37\u660e\u5fb3\u300cHow I treat NTRK gene fusion-positive cancers\u300d\u30f4\u30a1\u30a4\u30c8\u30e9\u30c3\u30af\u30d3\u767a\u58f21\u5468\u5e74Web\u8b1b\u6f14\u4f1a\u30002022.8\uff08Web\uff09<\/li>\n\n\n\n<li>\u83c5\u8c37\u660e\u5fb3\u300c\u30a8\u30f3\u30cf\u30fc\u30c4\u3092\u81e8\u5e8a\u3067\u3069\u3046\u6d3b\u304b\u3059\u304b\u3000\uff0d\u5f8c\u65b9\u30e9\u30a4\u30f3\u306b\u3064\u306a\u3050\u6cbb\u7642\u3092\u8003\u3048\u308b\uff0d\u300dGastric Cancer Web Seminar in Ibaraki\u30002022.9\uff08Web\uff09<\/li>\n\n\n\n<li>\u77f3\u9ed2\u613c\u543e\u300c\u304c\u3093\u60a3\u8005\u3055\u3093\u306eQOL \u3092\u4e0a\u3052\u308b\u6f22\u65b9\u85ac\u3092\u4f7f\u3044\u3053\u306a\u305d\u3046\u300d \u7814\u4fee\u533b\u306e\u305f\u3081\u306eKampo\u30a6\u30a7\u30d3\u30ca\u30fc 2022.9 (Web)<\/li>\n\n\n\n<li>\u83c5\u8c37\u660e\u5fb3\u300c\u5f53\u9662\u306b\u304a\u3051\u308b\u30e9\u30ed\u30c8\u30ec\u30af\u30c1\u30cb\u30d6\u4f7f\u7528\u7d4c\u9a13\uff5e\u51fa\u3057\u3066\u3088\u304b\u3063\u305fCGP\uff5e\u300d\u5927\u962a\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662\u30b2\u30ce\u30e0\u95a2\u9023\u8b1b\u6f14\u4f1a\uff08Web\uff092022.9<\/li>\n\n\n\n<li>\u83c5\u8c37\u660e\u5fb3\u300c\u907a\u4f1d\u5b50\u30d1\u30cd\u30eb\u691c\u67fb\u306e\u6e2c\u5b9a\u610f\u7fa9\u306b\u3064\u3044\u3066\u300d\u8328\u57ce\u770c\u770c\u592e\u770c\u5317\u304c\u3093\u907a\u4f1d\u5b50\u30d1\u30cd\u30ebweb\u30bb\u30df\u30ca\u30fc\u30002022.12<\/li>\n\n\n\n<li>\u83c5\u8c37\u660e\u5fb3\u3000\u98df\u9053\u764cClinical Practice Seminar\uff5e\u98df\u9053\u764c\u4e00\u6b21\u6cbb\u7642\u306e\u6700\u9069\u306a\u85ac\u7269\u7642\u6cd5\u3092\u8003\u3048\u308b\uff5e\uff08\u8328\u57ce\u30fb\u5343\u8449\uff09\u30b3\u30e1\u30f3\u30c6\u30fc\u30bf\u30fc\u30002023.3\uff08Web\uff09<\/li>\n\n\n\n<li>\u83c5\u8c37\u660e\u5fb3\u300c\u5927\u8178\u764c\u306e\u85ac\u7269\u7642\u6cd5\u3068\u7de9\u548c\u30b1\u30a2\u300d\u304c\u3093\u770c\u6c11\u516c\u958b\u30bb\u30df\u30ca\u30fc\uff49\uff4e\u307f\u3068\u30002022.12\uff08\u6c34\u6238\uff09<\/li>\n<\/ol>\n\n\n\n<h3 class=\"wp-block-heading\">\u4ee4\u548c3\u5e74\u5ea6<\/h3>\n\n\n\n<p>\u3010\u57f7\u7b46\u3011<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>\u83c5\u8c37\u660e\u5fb3. \u7c73\u56fd\u81e8\u5e8a\u816b\u760d\u5b66\u4f1a\uff08ASCO\uff092021\u901f\u5831\u30ec\u30dd\u30fc\u30c8 Poster Abstract #4027\u3000\u5207\u9664\u53ef\u80fd\u98df\u9053\u764c\u306b\u5bfe\u3059\u308b\u98df\u9053\u6a5f\u80fd\u6e29\u5b58\u3092\u76ee\u7684\u3068\u3057\u305f\u5c0e\u5165DCF\u7642\u6cd5\u306b\u3088\u308bchemoselection\u306e\u7b2cII\u76f8\u8a66\u9a13\uff08CROC\u8a66\u9a13\uff09 \u6d88\u5316\u5668\u764c\u306e\u5e83\u5834\uff08GI cancer-net) https:\/\/report.gi-cancer.net\/beirinsyo2021\/index.html<\/li>\n<\/ol>\n\n\n\n<p>\u3010\u8ad6\u6587\u3011<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Kawasaki H, Hoshikawa M, Kyoden Y, Iijima T, Kojima H, Yamamoto J.\u3000A locally advanced pancreatic body cancer presenting common bile duct invasion resected via distal pancreatectomy after gemcitabine plus nab-paclitaxel chemotherapy: A case report. Int J Surg Case Rep 2022; 92:106818<\/li>\n\n\n\n<li>Inada K, Kojima H, Cho-Isoda Y, Tamura R, Imamura G, Minami K,Nemoto T,and Yoshikawa G. Statistical Evaluation of Total Expiratory Breath Samples Collected throughout a Year: Reproducibility and Applicability toward Olfactory Sensor-Based Breath Diagnostics. Sensors (Basel) 2021; 21:4742.<\/li>\n\n\n\n<li>Moriwaki T, Gosho M, Sugaya A, Yamada T, Yamamoto Y, Hyodo I Optimal Maintenance Strategy for First-Line Oxaliplatin-Containing Therapy with or without Bevacizumab in Patients with Metastatic Colorectal Cancer: A Meta-Analysis Cancer Res Treat. 2021; 53:703-713.<\/li>\n\n\n\n<li>Wang X, Yamamoto Y, Imanishi M, Zhang X, Sato M, Sugaya A, Hirose M, Endo S, Natori Y, Moriwaki T, Yamato K, Hyodo I.Enhanced G1 arrest and apoptosis via MDM4\/MDM2 double knockdown and MEK inhibition in wild-type TP53 colon and gastric cancer cells with aberrant KRAS signaling Oncol Lett. 2021;22:558.<\/li>\n<\/ol>\n\n\n\n<p>\u3010\u5b66\u4f1a\u767a\u8868\u3011<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>\u83c5\u8c37\u660e\u5fb3.\u5e0c\u5c11\u907a\u4f1d\u5b50\u5909\u7570\u3092\u8003\u616e\u3057\u305f\u982d\u9838\u90e8\u764c\u306e\u6cbb\u7642\u6226\u7565\u3000\u5f53\u9662\u3067\u306e\u553e\u6db2\u817a\u764c\u75c7\u4f8b\u306b\u304a\u3051\u308b\u30e9\u30ed\u30c8\u30ec\u30af\u30c1\u30cb\u30d6\u306e\u4f7f\u7528\u7d4c\u9a13\u3000\u7b2c31\u56de\u65e5\u672c\u982d\u981a\u90e8\u5916\u79d1\u5b66\u4f1a\u7dcf\u4f1a\u306a\u3089\u3073\u306b\u5b66\u8853\u96c6\u4f1a\u3000\u30d0\u30a4\u30a8\u30eb\u85ac\u54c1\u682a\u5f0f\u4f1a\u793e\u5171\u50ac\u30bb\u30df\u30ca\u30fc\u30002022\u5e743\u6708\uff08\u5927\u962a\uff09<\/li>\n\n\n\n<li>\u5927\u795e\u6b63\u5b8f, \u7cf8\u8cc0\u667a\u5b50, \u5c0f\u5cf6\u5bdb. \u9ad8\u9f62\u8005\u80c3\u764c\u60a3\u8005\u306b\u304a\u3051\u308b\u9ad8\u9f62\u8005\u6a5f\u80fd\u8a55\u4fa1\u3068\u6cbb\u7642\u6210\u7e3e\u306e\u95a2\u9023. \u7b2c19\u56de\u65e5\u672c\u81e8\u5e8a\u816b\u760d\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, 2022\u5e742\u6708\uff08\u4eac\u90fd\uff09<\/li>\n<\/ol>\n\n\n\n<p>\u3010\u8b1b\u6f14\u3011<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>\u77f3\u9ed2\u613c\u543e\u300c\u304c\u3093\u6cbb\u7642\u306b\u304a\u3051\u308b\u6804\u990a\u7ba1\u7406\u306e\u91cd\u8981\u6027\u3000\u3084\u308c\u308b\u3053\u3068\u306f\u4f55\u3067\u3082\u3084\u308b\u300d\u304c\u3093\u60aa\u6db2\u8cea\u6cbb\u7642Online Seminar\u3000\u5c0f\u91ce\u85ac\u54c1\u5de5\u696d\u682a\u5f0f\u4f1a\u793e\u30002021.9.16<\/li>\n\n\n\n<li>\u77f3\u9ed2\u613c\u543e\u300c\u304c\u3093\u8a3a\u7642\u306e\u73fe\u72b6\u3068\u672a\u6765\u3000\u30b2\u30ce\u30e0\u533b\u7642\u300d\u8328\u57ce\u304c\u3093\u30d5\u30a9\u30fc\u30e9\u30e0\uff12\uff10\uff12\uff11\u30002021.10.24<\/li>\n\n\n\n<li>\u77f3\u9ed2\u613c\u543e\u300c\u52e4\u52d9\u533b\u3068\u5f80\u8a3a\u533b\u306e\u9023\u643a\u3067\u3053\u3053\u307e\u3067\u51fa\u6765\u308b\u5728\u5b85\u7de9\u548c\u533b\u7642\u300d\uff5e\u5730\u57df\u3067\u60a3\u8005\u3055\u3093\u3092\u8a3a\u308b\u30b7\u30ea\u30fc\u30ba\uff5e\u304c\u3093\u7de9\u548c\u30b1\u30a2\u5730\u57df\u9023\u643a\u306e\u4f1a \u7b2c\u4e00\u4e09\u5171\u682a\u5f0f\u4f1a\u793e\u30002022.2.7<\/li>\n<\/ol>\n\n\n\n<h3 class=\"wp-block-heading\">\u4ee4\u548c2\u5e74\u5ea6<\/h3>\n\n\n\n<p>\u3010\u8ad6\u6587\u3011<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Suzuki H, Yamada T, Sugaya A, Ueyama S, Yamamoto Y, Moriwaki T, Hyodo I.\u3000Retrospective analysis for the efficacy and safety of nivolumab in advanced gastric cancer patients according to ascites burden.\u3000 Int J Clin Oncol. 26(2):370-377, 2021. \u3000(2021.2)<\/li>\n\n\n\n<li>Zhang X, Yamamoto Y, Wang X, Sato M, Imanishi M, Sugaya A, Hirose M, Endo S, Moriwaki T, Yamato K, Hyodo I.&nbsp; MDM4 as a Prognostic Factor for Patients With Gastric Cancer With Low Expression of p53. Anticancer Res. 41(3):1475-1483, 2021.\u3000\uff082021.3\uff09<\/li>\n\n\n\n<li>\u5916\u5c71\u771f\u5f66,&nbsp;\u5ee3\u6728\u8f1d\u96c4,&nbsp;\u5927\u8d8a\u9756,&nbsp;\u5c0f\u5cf6\u5bdb.&nbsp;\u9069\u6b63\u8f38\u8840\u3092\u76ee\u7684\u3068\u3057\u305f\u75c7\u4f8b\u691c\u8a0e\u4f1a\u306b\u304a\u3051\u308b\u81e8\u5e8a\u691c\u67fb\u6280\u5e2b\u306b\u3088\u308b\u5168\u8f38\u8840\u75c7\u4f8b\u306e\u59a5\u5f53\u6027\u8a55\u4fa1.&nbsp;\u65e5\u672c\u8f38\u8840\u7d30\u80de\u6cbb\u7642\u5b66\u4f1a\u96d1\u8a8c&nbsp;2021; 67:43-47.<\/li>\n\n\n\n<li>\u4e09\u6a4b\u5f70\u4e00, \u5ee3\u7560\u5e83\u5b9f, \u5c0f\u5cf6\u5bdb, \u67f3\u5ddd\u5fb9. \u7de9\u548c\u30b1\u30a2\u533b\u7642\u306b\u304a\u3051\u308b\u6b6f\u79d1\u533b\u5e2b\u3068\u6b6f\u79d1\u885b\u751f\u58eb\u306e\u5f79\u5272\u3063\u3066\u3001\u30ca\u30f3\u30c0\uff1f. \u88dc\u7db4\u81e8\u5e8a 2021; 54(1):56-83.<\/li>\n\n\n\n<li>\u77f3\u9ed2\u613c\u543e, \u5c0f\u5cf6\u5bdb, \u5c71\u7e23\u61b2\u53f8, \u67f3\u5ddd\u5fb9. \u300c\u5316\u5b66\u7642\u6cd5\u3068\u53e3\u8154? \u3069\u3046\u3044\u3046\u95a2\u4fc2?\u300d.\u88dc\u7db4\u81e8\u5e8a 2020; 53(3): 296-314.<\/li>\n<\/ol>\n\n\n\n<p>\u3010\u5b66\u4f1a\u767a\u8868\u3011<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>\u83c5\u8c37\u660e\u5fb3\u3001\u5f53\u9662\u306b\u304a\u3051\u308b\u5207\u9664\u4e0d\u80fd\u9032\u884c\u30fb\u518d\u767a\u5927\u8178\u764c\u306eTAS-102\u306e\u4f7f\u7528\u7d4c\u9a13. &nbsp;\u7b2c106\u56de\u65e5\u672c\u6d88\u5316\u5668\u75c5\u5b66\u4f1a\u7dcf\u4f1a, 2020.8 (\u8a8c\u4e0a\u767a\u8868)<\/li>\n\n\n\n<li>\u83c5\u8c37\u660e\u5fb3\u3001\u5f53\u9662\u306b\u304a\u3051\u308b\u5207\u9664\u4e0d\u80fd\u9032\u884c\u30fb\u518d\u767a\u80c3\u764c\u306b\u5bfe\u3059\u308b\u30cb\u30dc\u30eb\u30de\u30d6\u306e\u4f7f\u7528\u6210\u7e3e. \u7b2c92\u56de\u65e5\u672c\u80c3\u764c\u5b66\u4f1a\u7dcf\u4f1a, 2020.8\uff08\u8a8c\u4e0a\u767a\u8868\uff09<\/li>\n<\/ol>\n\n\n\n<p>\u3010\u8b1b\u6f14\u3011<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>\u77f3\u9ed2\u613c\u543e\u3000\u30c1\u30fc\u30e0\u533b\u7642\u306b\u304a\u3051\u308b\u300e\u304c\u3093\u306e\u75db\u307f\u306e\u8efd\u6e1b\u300f. \u30d2\u30c9\u30ed\u30e2\u30eb\u30d5\u30a9\u30f3Web\u30bb\u30df\u30ca\u30fc2020.9(Web)<\/li>\n\n\n\n<li>\u77f3\u9ed2\u613c\u543e\u3000\u304c\u3093\u907a\u4f1d\u5b50\u30d1\u30cd\u30eb\u691c\u67fb-\u304c\u3093\u30b2\u30ce\u30e0\u533b\u7642.\u3000\u5730\u57df\u533b\u7642\u9023\u643a\u63a8\u9032\u61c7\u8ac7\u4f1a, 2020.11(\u8328\u57ce\u770c\u7acb\u4e2d\u592e\u75c5\u9662)<\/li>\n\n\n\n<li>\u83c5\u8c37\u660e\u5fb3\u3001\u5f53\u9662\u306b\u304a\u3051\u308b\u80c3\u304c\u3093\u306b\u5bfe\u3059\u308b\u5f8c\u65b9\u30e9\u30a4\u30f3\u6cbb\u7642\uff0e\u3000GI Cancer Chemotherapy Meeting 2020 in Mito, 2020.12 (Web)<\/li>\n\n\n\n<li>\u83c5\u8c37\u660e\u5fb3\u3001\u5f53\u9662\u306b\u304a\u3051\u308bnivolumab\u3067\u306e\u80c3\u764c\u6cbb\u7642\uff5e\u8179\u6c34\u3001\u8179\u819c\u64ad\u7a2e\u75c7\u4f8b\u3092\u4e2d\u5fc3\u306b\uff5e\uff0e\u3000\u8328\u57ce\u770c\u592e\u770c\u5317\u4e0a\u90e8\u6d88\u5316\u7ba1Web\u30bb\u30df\u30ca\u30fc\uff0c\u30002020.12 \uff08Web\uff09<\/li>\n\n\n\n<li>\u77f3\u9ed2\u613c\u543e\u3000Best supportive care\u306f\u672c\u5f53\u306bBest\u304b\uff1fPain control\u3092\u8003\u3048\u76f4\u3059. Gastric Cancer Web Seminar in Ibaraki 2021.1\uff08Web\uff09<\/li>\n<\/ol>\n\n\n\n<h3 class=\"wp-block-heading\">\u4ee4\u548c\u5143\u5e74<\/h3>\n\n\n\n<ol class=\"wp-block-list\">\n<li>\u77f3\u9ed2\u613c\u543e, \u5c0f\u5cf6\u5bdb, \u5800\u5149\u96c4, \u7530\u6751\u667a\u5b8f, \u85e4\u679d\u771f\u53f8, \u77f3\u5802\u4f73\u4e16, \u658e\u85e4\u8aa0. BRACAnalysis\u691c\u67fb\u3068PARP\u963b\u5bb3\u5264\u300c\u30aa\u30e9\u30d1\u30ea\u30d6\u300d\u306e\u51e6\u65b9\u3092\u53ef\u80fd\u3068\u3059\u308b\u969b\u306b\u5fc5\u8981\u306a\u9662\u5185\u591a\u8077\u7a2e\u306b\u3088\u308b\u30c1\u30fc\u30e0\u533b\u7642\u3068\u305d\u306e\u5fdc\u7528. <a>\u7b2c<\/a>17\u56de\u65e5\u672c\u81e8\u5e8a\u816b\u760d\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, 2019.7\uff08\u4eac\u90fd\uff09<\/li>\n\n\n\n<li>&nbsp;Akinori Sugaya, Shunsuke Ueyama, Hirosumi Suzuki, Takeshi Yamada, Yoshiyuki Yamamoto, Toshikazu Moriwaki, Ichinosuke Hyodo. Retrospective analysis for efficacy and safety of nivolumab in advanced gastric cancer patients (pts) with malignant ascites. Gastrointestinal Cancers Symposium 2020 (ASCO-GI 2020), 2020.1\u3000(San Francisco, USA)<\/li>\n\n\n\n<li>\u77f3\u9ed2\u613c\u543e\u3001\u5c0f\u5cf6\u5bdb\u3001\u4e09\u6a4b\u5f70\u4e00\u3001\u83c5\u8c37\u660e\u5fb3\u3001\u9f4b\u85e4\u8aa0\u3001\u77f3\u5802\u4f73\u4e16. \u304c\u3093\u907a\u4f1d\u5b50\u30d1\u30cd\u30eb\u691c\u67fb\u5c0e\u5165\u306b\u969b\u3057\u3066\u306a\u3059\u3079\u304d\u3053\u3068.\u3000\u7b2c58\u56de\u5168\u56fd\u81ea\u6cbb\u4f53\u75c5\u9662\u5b66\u4f1a, 2019.10\uff08\u5fb3\u5cf6\uff09<\/li>\n\n\n\n<li>\u5927\u795e\u6b63\u5b8f\u3001\u5c71\u4e0b\u771f\u4ee5\u3001\u5e02\u585a\u4e9c\u7531\u7f8e\u3001\u576a\u5c71\u52dd\u5e73\u3001\u5c0f\u5cf6\u53cb\u6075\u3001\u5f8c\u85e4\u3072\u304b\u308b\u3001\u5c0f\u5cf6\u5bdb\u3001\u9ed2\u6fa4\u8c4a\u5f66\uff0e\u5916\u6765\u5316\u5b66\u7642\u6cd5\u306b\u304a\u3051\u308b\u91cd\u7be4\u306a\u6709\u5bb3\u4e8b\u8c61\u306e\u767a\u751f\u72b6\u6cc1\u306b\u95a2\u3059\u308b\u691c\u8a0e\uff0e\u7b2c17\u56de\u65e5\u672c\u81e8\u5e8a\u816b\u760d\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e2019.7(\u4eac\u90fd)<\/li>\n\n\n\n<li>\u4e94\u8012\u4f73\u592e\u91cc\u3001\u5927\u795e\u6b63\u5b8f\u3001\u5e02\u585a\u4e9c\u7531\u7f8e\u3001\u576a\u5c71\u52dd\u5e73\u3001\u5cf6\u7530\u6d69\u548c\u3001\u5c0f\u5cf6\u53cb\u6075\u3001\u9234\u6728\u9ebb\u7d17\u5b50\u3001\u8352\u6728\u771e\u88d5\u3001\u5c0f\u5cf6\u5bdb\u3001\u9234\u6728\u7f8e\u52a0\uff0e\u514d\u75ab\u6291\u5236\u30fb\u5316\u5b66\u7642\u6cd5\u60a3\u8005\u306b\u304a\u3051\u308bB\u578b\u809d\u708e\u30a6\u30a4\u30eb\u30b9\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u5b9f\u65bd\u72b6\u6cc1\u8abf\u67fb\uff0e\u65e5\u672c\u75c5\u9662\u85ac\u5264\u5e2b\u4f1a\u95a2\u6771\u30d6\u30ed\u30c3\u30af\u7b2c49\u56de\u5b66\u8853\u5927\u4f1a\uff0e2019.8(\u5c71\u68a8)<\/li>\n\n\n\n<li>\u5927\u795e\u6b63\u5b8f\u3001\u5c0f\u5cf6\u5bdb\u3001\u5c71\u4e0b\u771f\u4ee5\u3001\u5e02\u585a\u4e9c\u7531\u7f8e\u3001\u4e94\u8012\u4f73\u592e\u91cc\u3001\u576a\u5c71\u52dd\u5e73\u3001\u5c0f\u5cf6\u53cb\u6075\u3001\u9234\u6728\u7f8e\u52a0\uff0e\u5916\u6765\u5316\u5b66\u7642\u6cd5\u306b\u304a\u3051\u308b\u9ad8\u9f62\u8005\u306e\u6a5f\u80fd\u8a55\u4fa1\u3068\u6cbb\u7642\u306e\u5b9f\u614b\u8abf\u67fb\uff0e\u7b2c29\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a\uff0e2019.11(\u798f\u5ca1)<\/li>\n\n\n\n<li>\u67f4\u3053\u306e\u307f\u3001\u5927\u795e\u6b63\u5b8f\u3001\u7acb\u539f\u8302\u6a39\u3001\u5e02\u585a\u4e9c\u7531\u7f8e\u3001\u77f3\u5ddd\u6d0b\u8f14\u3001\u5cf6\u7530\u6d69\u548c\u3001\u5c0f\u5cf6\u53cb\u6075\u3001\u9234\u6728\u7f8e\u52a0\uff0e\u304c\u3093\u85ac\u7269\u7642\u6cd5\u306b\u304a\u3051\u308b\u8077\u696d\u6027\u66b4\u9732\u5bfe\u7b56\u8abf\u67fb\uff0e\u7b2c29\u56de\u8328\u57ce\u304c\u3093\u5b66\u4f1a\uff0e2019.12(\u8328\u57ce)<\/li>\n<\/ol>\n\n\n\n<p>\u3010\u8b1b\u6f14\u3011<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>\u77f3\u9ed2\u613c\u543e. \u300e\u4e73\u764c\u306e\u5185\u5206\u6ccc\u7642\u6cd5\u3092\u652f\u3048\u308b\u85ac\u5264\u5e2b\u306e\u5f79\u5272\u300f\uff5e\u671f\u5f85\u3055\u308c\u308b\u80fd\u529b\u3068\u306f\uff1f\uff5e.\u3000\u4ee4\u548c\u5143\u5e74\u5ea6 \u7b2c1\u56de\u7b20\u9593\u5730\u533a\u85ac\u85ac\u9023\u643a\u7814\u4fee\u4f1a. 2019.6\uff08\u7b20\u9593\uff09<\/li>\n\n\n\n<li>\u77f3\u9ed2\u613c\u543e.\u3000\u7de9\u548c\u30b1\u30a2 \u301c\u304c\u3093\u60a3\u8005\u306e\u75bc\u75db\u7ba1\u7406\u306b\u304a\u3044\u3066\u671f\u5f85\u3055\u308c\u308b\u85ac\u5264\u5e2b\u306e\u5f79\u5272\u301c\u7b2c17\u56de\u65e5\u672c\u5973\u6027\u85ac\u5264\u5e2b\u4f1a\u3000\u5168\u56fd\u79fb\u52d5\u30bb\u30df\u30ca\u30fcin\u8328\u57ce\u3001\u7b2c47\u56de\u65e5\u672c\u5973\u6027\u85ac\u5264\u5e2b\u4f1a\u3000\u95a2\u6771\u30d6\u30ed\u30c3\u30af\u7814\u4fee\u4f1a. 2019.10\uff08\u6c34\u6238\uff09<\/li>\n\n\n\n<li>\u77f3\u9ed2\u613c\u543e\uff08\u4f01\u753b\u7acb\u6848\u53f8\u4f1a\uff09\u514d\u75ab\u30c1\u30a7\u30c3\u30af\u30dd\u30a4\u30f3\u30c8\u963b\u5bb3\u85ac\uff0d\u5b89\u5168\u5bfe\u7b56\u3092\u8003\u3048\u308b\uff0e\u304c\u3093\u8a3a\u7642\u9023\u643a\u62e0\u70b9\u75c5\u9662\u8b1b\u6f14\u4f1a\uff0e2019.10 (\u7b20\u9593)<\/li>\n\n\n\n<li>\u77f3\u9ed2\u613c\u543e. \u300c\u304c\u3093\u300d\u3092\u5b66\u3073\u4f55\u304c\u3067\u304d\u308b\u304b\u8003\u3048\u3088\u3046.\u3000\u7b20\u9593\u5e02\u7acb\u7b20\u9593\u4e2d\u5b66\u6821\u304c\u3093\u6559\u80b2\u8b1b\u6f14\u4f1a\uff0e2019.12\uff08\u7b20\u9593\uff09<\/li>\n\n\n\n<li>\u83c5\u8c37\u660e\u5fb3.\u3000\u5316\u5b66\u7642\u990a\u4e2d\u306e\u60a3\u8005\u306b\u304a\u3051\u308b\u81e8\u5e8a\u691c\u67fb\u5024\u306e\u8aad\u307f\u65b9.\u3000\u8328\u57ce\u770c\u304c\u3093\u8a3a\u7642\u9023\u643a\u62e0\u70b9\u75c5\u9662\u7814\u4fee\u4f1a.2019.10\uff08\u7b20\u9593\uff09<\/li>\n<\/ol>\n\n\n\n<h3 class=\"wp-block-heading\">\u5e73\u621030\u5e74\u5ea6<\/h3>\n\n\n\n<p>\u3010\u539f\u8457\u3011<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Tanaka K, Toyota S, Akiyama M, Wakimoto N, Nakamura Y, Najima Y, Doki N, Kakihana K, Igarashi A, Kobayashi T, Ohashi K, Kudo D, Shinagawa A, Takano H, Fujio T, Okoshi Y, Hori M, Kumagai T, Saito T, Mukae J, Yamamoto K, Tsutsumi I, Komeno T, Yoshida C, Yamamoto M, and Kojima H; on behalf of the Ochanomizu Hematology Study Group. Efficacy and safety of weekly cyclophosphamide-bortezomib-dexamethasone (CBD) regimen as induction therapy prior to autologous stem cell transplantation in Japanese patients with newly diagnosed multiple myeloma. -A phase 2 multicenter trial- Acta Haematologica 2019; 141:111-118.<\/li>\n\n\n\n<li>KajikawaN, SekiY, FujioT, OkoshiY, HoriM, SaitoH, IijimaT, Kojima H. Central nervous system lymphoma harboring the JAK2 V617F mutation that developed after 20-year history of polycythemia vera. Intern Med 2018; 57:3293-3297.<\/li>\n\n\n\n<li>Inada K, Okoshi Y, Cho-Isoda Y, Ishiguro S, Suzuki H, Oki A, Tamaki Y, Shimazui T, Saito H, Hori M, Iijima T, Kojima H. Endogenous reference RNAs for microRNA quantitation in formalin-fixed, paraffin-embedded lymph node tissue. Scientific Reports 2018; 8:5918.<\/li>\n<\/ol>\n\n\n\n<p>\u3010\u5b66\u4f1a\u767a\u8868\u3011<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>\u5cf6\u7530\u6d69\u548c, \u5927\u795e\u6b63\u5b8f, \u7acb\u539f\u8302\u6a39, \u6df1\u6fa4\u4e9c\u5b63\u5b50, \u9234\u6728\u4e00\u885b, \u5ca9\u4e0a\u667a\u7f8e, \u77f3\u5ddd\u6d0b\u8f14, \u4e94\u8012\u4f73\u592e\u91cc, \u5c0f\u5cf6\u53cb\u6075, \u8352\u6728\u771e\u88d5, \u5c0f\u5cf6\u5bdb, \u9ed2\u6fa4\u8c4a\u5f66. \u514d\u75ab\u6291\u5236\u30fb\u5316\u5b66\u7642\u6cd5\u60a3\u8005\u306b\u304a\u3051\u308bB\u578b\u809d\u708e\u30a6\u30a4\u30eb\u30b9\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u5b9f\u65bd\u72b6\u6cc1\u8abf\u67fb. \u7b2c28\u56de\u8328\u57ce\u304c\u3093\u5b66\u4f1a, 2019.<\/li>\n\n\n\n<li>Kudo D, Komeno T, Yoshida C, Ota TI, Ohashi K, Kakihana K, Kobayashi T, Doki N, Najima Y, Igarashi A, Hori M, Okoshi Y, Fujio T, Shinagawa A, Yamamoto M, Takano H, Kumagai T, Yamamoto K, Toyota S, Nakamura Y, Kojima H. Efficacy and safety of once-weekly cyclophosphamide-bortezomib-dexamethasone (CBD) regimen as induction therapy prior to autologous stem cell transplantation in Japanese patients with newly diagnosed multiple myeloma. -a phase 2 multicenter trial- 60th annual meeting of the American Society of Hematology, 2018.<\/li>\n\n\n\n<li>\u77f3\u9ed2\u613c\u543e, \u5c0f\u5cf6\u5bdb, \u98ef\u5cf6\u4e00\u98db, \u4e09\u6a4b\u5f70\u4e00, \u85e4\u679d\u771f\u53f8, \u7530\u6751\u667a\u5b8f, \u5927\u8d8a\u9756, \u5800\u5149\u96c4. \u60a3\u8005\u6559\u80b2\u3092\u542b\u3081\u305f\u30c1\u30fc\u30e0\u533b\u7642\u306b\u3088\u308b\u30c8\u30e9\u30d9\u30af\u30c6\u30b8\u30f3\u306e\u5b89\u5168\u306a\u6295\u4e0e\u7ba1\u7406\u65b9\u6cd5\uff0e<a>\u7b2c<\/a>16\u56de\u65e5\u672c\u81e8\u5e8a\u816b\u760d\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, 2018.<\/li>\n<\/ol>\n\n\n\n<h3 class=\"wp-block-heading\">\u5e73\u621029\u5e74\u5ea6<\/h3>\n\n\n\n<p>\u3010\u539f\u8457\u3011<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>\u8c37\u5ddd\u9053<a>\u6d69<\/a>, \u5c71\u53e3\u606d\u5b50, \u5927\u6c5f\u548c\u7d00, \u7fbd\u77f3\u9756<a>\u6d69<\/a>, \u77f3\u91ce\u306f\u308b\u307f, \u77f3\u6e21\u52c7, \u4f0a\u85e4\u5b5d\u7f8e, \u5927\u77f3\u6bc5, \u9d28\u4e0b\u660c\u6674, \u6728\u6751\u670b\u6587, \u5c0f\u6c60\u548c\u4fca, \u7c73\u91ce\u7422\u54c9, \u4f50\u85e4\u7d14\u4e00, \u4f50\u85e4\u5b8f\u559c, \u4f50\u85e4\u85e4\u592b, \u4f50\u85e4\u7950\u4e8c, \u767d\u5ddd\u6d0b\u5b50, \u54c1\u5ddd\u7be4\u53f8, \u5fb3\u6c38\u771f\u5f13, \u702c\u53e3\u96c5\u4eba, \u6e05\u7530\u80b2\u7537, \u9ad8\u6751\u6d69\u514b, \u9577\u8c37\u5ddd\u96c4\u4e00, \u8af8\u5ca1\u4fe1\u88d5, \u5c0f\u5cf6\u5bdb, \u5927\u8d8a\u9756. \u8328\u57ce\u770c\u5408\u540c\u8f38\u8840\u7642\u6cd5\u59d4\u54e1\u4f1a\u767a\u8db3\u5f8c5\u5e74\u9593\u306e\u6d3b\u52d5. \u65e5\u672c\u8f38\u8840\u7d30\u80de\u6cbb\u7642\u5b66\u4f1a\u8a8c 2017; 63:630-633.<\/li>\n\n\n\n<li>Yoshida K, Fujisawa F, Kojima H, Takeyasu N. Hemodynamic collapse due to the stenosis of 4 pulmonary veins in a patient with mediastinal tumor. Clin Case Rep 2017; 5:1030-1031.<\/li>\n\n\n\n<li>Fukushima M, Okoshi Y, Fukazawa K, Koshino M, Ishiguro S, Mitsuhashi S, Saitoh H, Iijima T, Kojima H, Hori M. A case of lymphoplasmacytic lymphoma presenting diarrhea and joint pain, successfully diagnosed by MYD88 mutation analysis. Intern Med 2017; 56:847-851.<\/li>\n<\/ol>\n\n\n\n<p>\u3010\u5b66\u4f1a\u767a\u8868\u3011<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>\u5927\u795e\u6b63\u5b8f, \u5c0f\u5cf6\u5bdb, \u9ed2\u6fa4\u8c4a\u5f66. \u5916\u6765\u304c\u3093\u5316\u5b66\u7642\u6cd5\u306b\u304a\u3051\u308b\u6551\u6025\u53d7\u8a3a\u306e\u5b9f\u614b\u8abf\u67fb. \u7b2c27\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a, 2017.<\/li>\n\n\n\n<li>Hori M, Ikebe E, Fajardo L, Ikebe T, Kojima H, Iha H. Evidence of SLAM7 expression among multiple lineages of hematologic malignancy. \u7b2c79\u56de\u65e5\u672c\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, 2017.<\/li>\n\n\n\n<li>\u7a32\u7530\u52dd\u91cd, \u5927\u8d8a\u9756, \u5f35\u6109\u7d00\u5b50, \u98ef\u5d8b\u9054\u751f, \u5800\u5149\u96c4, \u5c0f\u5cf6\u5bdb. \u30ea\u30f3\u30d1\u7bc0\u7d44\u7e54\u3092\u7528\u3044\u308bmicroRNA\u89e3\u6790\u306b\u9069\u3057\u305f\u5185\u5728\u6027\u907a\u4f1d\u5b50\u306e\u9078\u51fa. \u7b2c76\u56de\u65e5\u672c\u764c\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, 2017.<\/li>\n\n\n\n<li>\u5927\u8d8a\u9756, \u77f3\u6e21\u52c7, \u5c0f\u6c60\u548c\u5f66, \u7c73\u91ce\u7422\u54c9, \u4f50\u85e4\u7950\u4e8c, \u9577\u8c37\u5ddd\u96c4\u4e00, \u4f50\u85e4\u85e4\u592b, \u9d28\u4e0b\u660c\u6674, \u4f0a\u85e4\u5b5d\u7f8e, \u54c1\u5ddd\u7be4\u53f8, \u5fb3\u6c38\u771f\u5f13, \u4f50\u85e4\u5b8f\u559c, \u767d\u5ddd\u6d0b\u5b50, \u702c\u53e3\u96c5\u4eba, \u6728\u6751\u670b\u6587, \u6e05\u7530\u80b2\u7537, \u4f50\u85e4\u7d14\u4e00, \u7a32\u8449\u980c\u4e00, \u5c0f\u5cf6\u5bdb, \u8af8\u5ca1\u4fe1\u88d5. \u7523\u79d1\u65bd\u8a2d\u3067\u9069\u5207\u306b\u7ba1\u7406\u3055\u308c\u305f\u8840\u6db2\u88fd\u5264\u306e\u8fd4\u5374\u30fb\u8ee2\u7528\u306e\u5b9f\u73fe\u6027\u306b\u3064\u3044\u3066\u306e\u8abf\u67fb\u7814\u7a76\u2015\u8328\u57ce\u770c\u5408\u540c\u8f38\u8840\u59d4\u54e1\u4f1a. \u7b2c65\u56de\u65e5\u672c\u8f38\u8840\u30fb\u7d30\u80de\u6cbb\u7642\u5b66\u4f1a\u7dcf\u4f1a, 2017.<\/li>\n\n\n\n<li>\u4e0a\u59bb\u884c\u5247, \u5c0f\u5cf6\u5bdb, \u6cbc\u77e5\u5948\u4fdd\u5b50, \u4e8c\u5bae\u6cbb\u5f66. \u5de8\u6838\u7403\u9020\u8840\u306b\u304a\u3051\u308b\u6297\u8840\u5c0f\u677f\u6297\u4f53\u306e\u5f71\u97ff. \u2015\u514d\u75ab\u6027\u8840\u5c0f\u677f\u6e1b\u5c11\u75c7\u30e2\u30c7\u30eb\u30de\u30a6\u30b9\u3092\u7528\u3044\u305f\u691c\u8a0e\u2015 \u7b2c39\u56de\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, 2017.<\/li>\n\n\n\n<li>\u77f3\u9ed2\u613c\u543e, \u5c0f\u5cf6\u5bdb, \u98ef\u5cf6\u4e00\u98db, \u85e4\u679d\u771f\u53f8, \u7530\u6751\u667a\u5b8f, \u85e4\u5c3e\u9ad8\u884c, \u5800\u5149\u96c4. \u814b\u7aa9\u30ea\u30f3\u30d1\u7bc0\u306e\u307f\u306b\u8ee2\u79fb\u3092\u6709\u3059\u308b\u5973\u6027\u306e\u539f\u767a\u4e0d\u660e\u764c\uff08\u6f5c\u5728\u6027\u4e73\u764c\uff09\u306f\u4e73\u623f\u5168\u6458\u51fa\u8853\u3092\u7701\u7565\u3067\u304d\u308b\u304b. \u7b2c15\u56de\u65e5\u672c\u81e8\u5e8a\u816b\u760d\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, 2017.<\/li>\n<\/ol>\n\n\n\n<h3 class=\"wp-block-heading\">\u5e73\u621028\u5e74\u5ea6<\/h3>\n\n\n\n<p>\u3010\u8457\u66f8\u3011<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>\u5c0f\u5cf6\u5bdb. \u4e8c\u6b21\u6027\u8ca7\u8840. \u81e8\u5e8a\u533b\u30de\u30cb\u30e5\u30a2\u30eb\u7b2c\uff15\u7248\uff08\u81e8\u5e8a\u533b\u30de\u30cb\u30e5\u30a2\u30eb\u7de8\u96c6\u59d4\u54e1\u4f1a\u7de8\uff09\u533b\u6b6f\u85ac\u51fa\u7248\u682a\u5f0f\u4f1a\u793e 2016; pp1533-1536.<\/li>\n<\/ol>\n\n\n\n<p>\u3010\u539f\u8457\u3011<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Fukushima M, Okoshi Y, Fukazawa K, Koshino M, Ishiguro S, Mitsuhashi S, Saitoh H, Iijima T, Kojima H, Hori M. A case of lymphoplasmacytic lymphoma presenting diarrhea and joint pain, successfully diagnosed by MYD88 mutation analysis. Intern Med 2017; 56:847-851.<\/li>\n\n\n\n<li>Ohgami M, Homma M, Suzuki Y, Naito K, Yamada M, Mitsuhashi S, Fujisawa F, Kojima H, Kaburagi T, Uchiumi K, Yamada Y, Bando H, Hara H, Takei K. A simple high-performance liquid chromatography for determining lapatinib and erlotinib in human plasma. Ther Drug Monit 2016; 38:657-662.<\/li>\n\n\n\n<li>Sugaya A, Ishiguro S, Mitsuhashi S, Abe M, Hashimoto I, Kaburagi T, Kojima H. Interstitial lung disease associated with trastuzumab monotherapy: A report of 3&nbsp;cases. Mol Clin Oncol 2016; 6:229-232.<\/li>\n\n\n\n<li>\u8429\u539f\u4f50\u6075\u5b50\u3001\u6c38\u6c5f\u7f8e\u9999\u5b50\u3001\u72e9\u91ce\u4fca\u5e78\u3001\u5c0f\u5cf6\u5bdb\uff1a\u76ae\u819a\u8ee2\u79fb\u3092\u304d\u305f\u3057\u305f\u591a\u767a\u6027\u9aa8\u9ac4\u816b. \u76ae\u819a\u81e8\u5e8a 2016; 58:1515-1518.<\/li>\n\n\n\n<li>Kanaya M, Shibuya K, Hirochika R, Kanemoto M, Ohashi K, Okada M, Wagatsuma, Cho Y, Kojima H, Teshima T, Imamura M, Sakamaki H, Shibuya A. Soluble DNAM-1, as a predictive biomarker for acute graft-versus-host disease. PLoS One 2016; 11(6):e0154173.<\/li>\n\n\n\n<li>Iguchi-Manaka A, Okumura G, Kojima H, Cho Y, Hirochika R, Bando H, Sato T, Yoshikawa H, Hara H, Shibuya A, Shibuya K. Increased soluble CD155 in the serum of cancer patients. PLoS One 2016; 11(4):e0152982.<\/li>\n\n\n\n<li>Yamamoto M, Ohashi K, Kakihana K, Nakamura Y, Komeno T, Kojima H, Morita S, Sakamaki H. A multicenter clinical study to determine the feasible initial dose of lenalidomide for maintenance therapy in patients with multiple myeloma following autologous peripheral blood stem cell transplantation. Mol Clin Oncology 2016; 4:965-970.<\/li>\n<\/ol>\n\n\n\n<p>\u3010\u5b66\u4f1a\u767a\u8868\u3011<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Cho Y, Inada K, Okoshi Y, Hori M, Kojima H. Comprehensive analysis of serum cytokines\/chemokines in myeloma patients for pursuing the abnormality in microenvironment and predicting the prognosis. 58th annual meeting of the American Society of Hematology, 2016.<\/li>\n\n\n\n<li>Hori M, Okoshi Y, Fujio T, Kojima H, Iha H, Ikebe E. Modulated mRNA expression profiles of a MM cell after a long-term exposure to lenalidomide. \u7b2c78\u56de\u65e5\u672c\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, 2016.<\/li>\n\n\n\n<li>Kudo D, Komeno T, Ohashi K, Nakamura Y, Shinagawa A, Suyama T, Yoshida C, Kobayashi T, Wakimoto N, Hori M, Okoshi Y, Kumagai T, Kato A, Toyota S, Yamamoto K, Yamamoto M, Kawai N, Ohwada A, Miki T, Sakamaki H, Kojima H. Efficacy and safety of CBD induction for ASCT-eligible NDMM -A phase 2 multicenter trial- \u7b2c78\u56de\u65e5\u672c\u8840\u6db2\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, 2016.<\/li>\n\n\n\n<li>\u77f3\u9ed2\u613c\u543e\u3001 \u5c0f\u5cf6\u5bdb\u3001 \u4e09\u6a4b\u5f70\u4e00\u3001 \u7a42\u7a4d\u5eb7\u592b\u3001 \u677e\u5c3e\u77e5\u5e73\u3001 \u5317\u539f\u7f8e\u7531\u7d00\u3001 \u98ef\u5cf6\u4e00\u98db\u3001 \u5800\u5149\u96c4\uff1a\u814b\u7aa9\u30ea\u30f3\u30d1\u7bc0\u306e\u307f\u306b\u8ee2\u79fb\u3092\u6709\u3059\u308b\u539f\u767a\u4e0d\u660e\u764c\u306e\u6cbb\u7642\u65b9\u91dd 2\u75c7\u4f8b\u306e\u691c\u8a0e. \u7b2c\uff15\uff15\u56de\u5168\u56fd\u81ea\u6cbb\u4f53\u75c5\u9662\u5b66\u4f1a\u3001 2016.<\/li>\n\n\n\n<li>\u77f3\u9ed2\u613c\u543e\u3001 \u85e4\u6fa4\u6587\u7d75\u3001 \u5800\u5149\u96c4\u3001 \u5c0f\u5cf6\u5bdb\uff1a\u9aa8\u9ac4\u6240\u898b\u306e\u5909\u5316\u3067paclitaxel\u306b\u3088\u308b\u6cbb\u7642\u7d99\u7d9a\u3092\u6c7a\u5b9a\u3057\u8457\u52b9\u3057\u305f\u4e73\u764c\u8853\u5f8c\u518d\u767a\u9aa8\u9ac4\u764c\u816b\u75c7\u306e\u4e00\u4f8b. \u7b2c\uff11\uff14\u56de\u65e5\u672c\u81e8\u5e8a\u816b\u760d\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u3001 2016.<\/li>\n\n\n\n<li>\u83c5\u8c37\u660e\u5fb3\u3001 \u77f3\u9ed2\u613c\u543e\u3001 \u4e09\u6a4b\u5f70\u4e00\u3001 \u5c0f\u5cf6\u5bdb\uff1a\u30c8\u30e9\u30b9\u30c4\u30ba\u30de\u30d6\u95a2\u9023\u9593\u8cea\u6027\u80ba\u708e\u306e3\u4f8b. \u7b2c\uff11\uff14\u56de\u65e5\u672c\u81e8\u5e8a\u816b\u760d\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u3001 2016.<\/li>\n\n\n\n<li>\u5f35\u6109\u7d00\u5b50\u3001 \u7a32\u7530\u52dd\u91cd\u3001 \u8d8a\u91ce\u7e6d\u5b50\u3001 \u5927\u8d8a\u9756\u3001 \u5800\u5149\u96c4\u3001 \u5c0f\u5cf6\u5bdb\uff1a\u591a\u767a\u6027\u9aa8\u9ac4\u816b\u60a3\u8005\u306e\u8840\u6e05\u4e2d\u30b5\u30a4\u30c8\u30ab\u30a4\u30f3\u30fb\u30b1\u30e2\u30ab\u30a4\u30f3\u306e\u7db2\u7f85\u7684\u6e2c\u5b9a\u306b\u57fa\u3065\u304f\u75c5\u614b\u30fb\u4e88\u5f8c\u89e3\u6790. \u7b2c\uff14\uff11\u56de\u65e5\u672c\u9aa8\u9ac4\u816b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u3001 2016.<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>\u5e73\u621028\u5e74\u5ea6\uff5e\u4ee4\u548c6\u5e74\u5ea6 \u4ee4\u548c6\u5e74\u5ea6 \u3010\u539f\u8457\u3011 \u3010\u5b66\u4f1a\u767a\u8868\u3011 \u3010\u8b1b\u6f14\u3011 \u4ee4\u548c5\u5e74\u5ea6 \u3010\u8ad6\u6587\u3011 \u4ee4\u548c4\u5e74\u5ea6 \u3010\u539f\u8457\u3011 \u3010\u5b66\u4f1a\u767a\u8868\u3011 \u3010\u8b1b\u6f14\u3011 \u4ee4\u548c3\u5e74\u5ea6 \u3010\u57f7\u7b46\u3011 \u3010\u8ad6\u6587\u3011 \u3010\u5b66\u4f1a\u767a\u8868\u3011 \u3010\u8b1b\u6f14\u3011 \u4ee4\u548c2\u5e74\u5ea6 \u3010\u8ad6\u6587\u3011 \u3010 [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":744,"menu_order":1,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":"","vk-ltc-link":"","vk-ltc-target":"0"},"class_list":["post-16934","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/wp-json\/wp\/v2\/pages\/16934","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/wp-json\/wp\/v2\/comments?post=16934"}],"version-history":[{"count":6,"href":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/wp-json\/wp\/v2\/pages\/16934\/revisions"}],"predecessor-version":[{"id":25116,"href":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/wp-json\/wp\/v2\/pages\/16934\/revisions\/25116"}],"up":[{"embeddable":true,"href":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/wp-json\/wp\/v2\/pages\/744"}],"wp:attachment":[{"href":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/wp-json\/wp\/v2\/media?parent=16934"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}